The single-agent treatment using EOAI3402143 or anti-PD-1 antibody significantly suppressed the tumor growth and enhanced the overall survival compared with the group of the control treatment (Supplementary Fig. 10h–j). This evidence concerns the gene PDCD1 and neoplasm.